Favourites   Have ideas?  Sign in / Register

Positive:   Radiotherapy ↓9.78   Country: Singapore ↓9.49   Country: China ↓8.82 «See more»   SaaS ↑4.05   Biology ↑6.11   Country: Canada ↑8.78

Negative:   Tobacco ↓0.6   Bad infrastructure  ↑1.53


Pharmaceutical segment

ACHV Achieve Life Sciences, Inc. - Common Shares -0.6% up -7.49% 6.89 + Pharmaceutical , Disease: Addictions
- Tobacco
+ My List
ACRX AcelRx Pharmaceuticals, Inc. - Common Stock 6.42% down 7.34% -0.92 + Pharmaceutical , Medicine


Last highlighted: Form 8-K: Results of Operations and Financial Condition On January 14, 2021, AcelRx Pharmaceuticals issued a press re.. $ACRX https://t.co/85kZEX2ul8
+ My List
ADMS Adamas Pharmaceuticals, Inc. - Common Stock 2.15% down 74.84% -72.69 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
ADXN Addex Therapeutics Ltd - American Depositary Shares -0.32% down 7.48% -7.8 + Medicine, Disease: Neurology/Alzheimer/Parkinson's, Pharmaceutical

+ My List
AERI Aerie Pharmaceuticals, Inc. - Common Stock -6.19% up -7.42% 1.23 + Disease: Eye , Medicine, Pharmaceutical


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $AERI AERIE PHARMACEUTICALS INC https://t.co/jhemDQoMVR
+ My List
AIKI AIkido Pharma Inc. - Common Stock -6.8% up -8.74% 1.94 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ANIP ANI Pharmaceuticals, Inc. - Common Stock -8.53% -8.53% 0 + Generic, Pharmaceutical , Medicine

+ My List
AQST Aquestive Therapeutics, Inc. - Common Stock 7.85% down 8.08% -0.23 + Medicine, Pharmaceutical

+ My List
ARDS Aridis Pharmaceuticals Inc. - Common Stock 14.7% 14.7% 0 + Disease: Infectious, Pharmaceutical , Medicine

+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares -9.49% down -7.59% -1.9 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
AUPH Aurinia Pharmaceuticals Inc - Common Shares 42.04% up 35.61% 6.43 + Pharmaceutical , Immunology, Country: Canada


Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -9.9% 9.9 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
BIMI BOQI International Medical Inc. - Common Stock -9.8% -9.8% 0 + Country: China, Medicine, Pharmaceutical

+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock -5.23% up -7.27% 2.04 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 65.42% down 65.56% -0.14 + Cancer fight, Medicine, Pharmaceutical

+ My List
CPRX Catalyst Pharmaceuticals, Inc. - Common Stock 8.06% up 5.1% 2.96 + Pharmaceutical , Medicine


Last highlighted: #CPRX SEC report: CATALYST PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by CATALYST PHARMACEUTICALS, INC. -- SEC File Number
+ My List
CRNX Crinetics Pharmaceuticals, Inc. - Common Stock 1.86% down 12.33% -10.47 + Pharmaceutical , Disease: Endocrine disease, Medicine


Last highlighted: #CRNX SEC report: Crinetics Pharmaceuticals, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Crinetics Pharmaceuticals, Inc. -- SEC File Number 211161145
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock -7.02% up -7.23% 0.21 + Medicine, Immunology, Pharmaceutical

+ My List
CTXR Citius Pharmaceuticals, Inc. - Common Stock -6.86% up -7.35% 0.49 + Pharmaceutical , Medicine


Last highlighted: #CTXR SEC report: Citius Pharmaceuticals, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Citius Pharmaceuticals, Inc. -- SEC File Number 211081579
+ My List
CTXRW Citius Pharmaceuticals, Inc. - Warrant up -10% 10 + Pharmaceutical , Medicine

+ My List
CYCC Cyclacel Pharmaceuticals, Inc. - Common Stock 3.06% down 7.03% -3.97 + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
+ My List
DRNA Dicerna Pharmaceuticals, Inc. - Common Stock -2.89% -2.89% 0 + Biopharma, Pharmaceutical , RNA, Medicine


Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/pVex4DfvFC 30s delayed.
+ My List
DYAI Dyadic International, Inc. - Common Stock -9.18% -9.18% 0 + Medicine, Biopharma, Pharmaceutical

+ My List
ENDP Endo International plc - Ordinary Shares -0.88% down 9.74% -10.62 + Medicine, Pharmaceutical , Country: Ireland, Generic


Last highlighted: Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2020 Update
+ My List
ENTX Entera Bio Ltd. - Ordinary Shares -1.90% -1.90% 0 + Country: Israel, Biotechnology, Pharmaceutical


Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd. https://t.co/dws8IKVGAV #healthcare
+ My List
ENTXW Entera Bio Ltd. - Warrant up -10.78% 10.78 + Country: Israel, Biotechnology, Pharmaceutical

+ My List
EPIX ESSA Pharma Inc. - Common Stock 7.13% up 4.51% 2.62 + Pharmaceutical , Country: Canada, Cancer fight


Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253
+ My List
ETON Eton Pharmaceuticals, Inc. - Common Stock down 7.94% -7.94 + Medicine, Pharmaceutical

+ My List
EVOK Evoke Pharma, Inc. - Common Stock down 7.2% -7.2 + Pharmaceutical , Medicine, Disease: Gastrointestinal


Last highlighted: FORM 8-K [Press/News Current Report] recently SEC filed. $EVOK Evoke Pharma Inc https://t.co/fwtsPe3b5z
+ My List
EYPT EyePoint Pharmaceuticals, Inc. - Common Stock 7.16% up 2.84% 4.32 + Pharmaceutical , Disease: Eye , Medicine, Biopharma


Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305
+ My List
FBIO Fortress Biotech, Inc. - Common Stock 6.95% down 9.6% -2.65 + Pharmaceutical , Biopharma, Biotechnology, Medicine

+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares -9.78% -9.78% 0 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
HRTX Heron Therapeutics, Inc. - Common Stock 6.81% down 7.11% -0.3 + Medicine, Pharmaceutical

+ My List
HUGE FSD Pharma Inc. - Class B Subordinate Voting Shares 4.73% down 14.19% -9.46 + Pharmaceutical , Medicine

+ My List
ICPT Intercept Pharmaceuticals, Inc. - Common Stock 7.12% up 5.25% 1.87 + Pharmaceutical , Medicine, Biopharma, Disease: Liver


Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number
+ My List
ITRM Iterum Therapeutics plc - Ordinary Share -40.74% up -41.67% 0.93 + Pharmaceutical , Medicine, Disease: Infectious

+ My List
KALV KalVista Pharmaceuticals, Inc. - Common Stock -6.75% up -7.17% 0.42 + Pharmaceutical , Medicine


Last highlighted: #KALV SEC report: KalVista Pharmaceuticals, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Filing Form 10-K filed by KalVista Pharmaceuticals, Inc. -- SEC File Number 211087997
+ My List
KMDA Kamada Ltd. - Ordinary Shares 6.53% down 9.97% -3.44 + Biopharma, Pharmaceutical , Medicine


Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938
+ My List
KNSA Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock 0.23% up -8.75% 8.98 + Pharmaceutical , Biopharma, Medicine


Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062
+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock -7.15% -7.15% 0 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock 8.55% 8.55% 0 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock 6.57% down 7.14% -0.57 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MTP Midatech Pharma PLC - American Depositary Shares 0.00% 0 + Country: Greate Britain, Medicine, 3D, Pharmaceutical


Last highlighted: $MTP 📜 SEC Form 6-K filed by Midatech Pharma PLC https://t.co/bXrzkJUXsF #majorpharmaceuticals #healthcare
+ My List
NEOS Neos Therapeutics, Inc. - Common Stock -26.21% -26.21% 0 + Medicine, Pharmaceutical , Disease: Neurology/Alzheimer/Parkinson's

+ My List
OCUP Ocuphire Pharma, Inc. - Common Stock -2.61% -2.61% 0 + Disease: Eye , Biopharma, Medicine, Pharmaceutical


Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits https://t.co/xMAN0ucl8b 15s delayed.
+ My List
OPNT Opiant Pharmaceuticals, Inc. - Common Stock 1.05% down 7.98% -6.93 + Pharmaceutical , Medicine, Alcohol, Cannabis


Last highlighted: #OPNT SEC report: OPIANT PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OPIANT PHARMACEUTICALS, INC. -- SEC File Number 211148259
+ My List
OPTN OptiNose, Inc. - Common Stock -1.3% down 8.9% -10.2 + Medicine, Disease: Ear/Nose, Pharmaceutical

+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock -11.26% -11.26% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
ORMP Oramed Pharmaceuticals Inc. - Common Stock -7.95% -7.95% 0 + Medicine, Pharmaceutical

+ My List
OSMT Osmotica Pharmaceuticals plc - Ordinary Shares -1.47% down 7.45% -8.92 + Pharmaceutical , Women Health, Biopharma

+ My List
PLXP PLx Pharma Inc. - Common Stock 4.96% down 7.24% -2.28 + Disease: Gastrointestinal, Medicine, Pharmaceutical

+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock -13.87% -13.87% 0 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
PRTK Paratek Pharmaceuticals, Inc. - Common Stock -7.84% up -8.82% 0.98 + Pharmaceutical , Biopharma, Medicine, Life Sciences

+ My List
RETA Reata Pharmaceuticals, Inc. - Class A Common Stock -0.04% up -7.19% 7.15 + Pharmaceutical , Disease: Kidney, Medicine

+ My List
RSSS Research Solutions, Inc - Common Stock 4.05% down 8.1% -4.05 + Life Sciences, SaaS, Pharmaceutical

+ My List
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock 4.33% down 7.96% -3.63 + Pharmaceutical , Gene and cell, Medicine


Last highlighted: #RYTM SEC report: RHYTHM PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by RHYTHM PHARMACEUTICALS, INC. -- SEC File Number 211137945
+ My List
SCPH scPharmaceuticals Inc. - Common Stock -6.83% up -7.13% 0.3 + Pharmaceutical , Medicine


Last highlighted: $SCPH [15s. delayed] filed form 8-K on July 01, 08:10:00: Item8.01: Other Material Events https://t.co/XvnQaKOhSx
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock 0.25% down 8.53% -8.28 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TENX Tenax Therapeutics, Inc. - Common Stock -4.74% up -7.89% 3.15 + Pharmaceutical , Medicine


Last highlighted: #TENX SEC report: TENAX THERAPEUTICS, INC. [Amend] General statement of acquisition of beneficial ownership
SEC Filing Form SC 13D/A filed by TENAX THERAPEUTICS, INC. -- SEC File Number 211083528
+ My List
TXMD TherapeuticsMD, Inc. - Common Stock up -8% 8 + Women Health, Pharmaceutical , Medicine
- Bad infrastructure

Last highlighted: #TXMD SEC report: TherapeuticsMD, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by TherapeuticsMD, Inc. -- SEC File Number 211142293
+ My List
VSPRU Vesper Healthcare Acquisition Corp. - Unit 4.74% down 7.44% -2.7 + Acquisitions/Investing, Healthcare, Medicine, Pharmaceutical


Last highlighted: $VSPRU [15s. delayed] filed form 8-K/A on April 27, 08:49:59: Item8.01: Other Material Events https://t.co/lO6rnv4ril
+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock -0.66% up -8.62% 7.96 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 6.11% down 7.69% -1.58 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
ZYNE Zynerba Pharmaceuticals, Inc. - Common Stock -6.52% up -7.49% 0.97 + Cannabis, Medicine, Pharmaceutical , Disease: Neuropsychiatric


Last highlighted: #ZYNE SEC report: Zynerba Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Zynerba Pharmaceuticals, Inc. -- SEC File Number 211089272
+ My List
CLVR Clever Leaves Holdings Inc. - Common Shares -7.6% -7.6% 0 + Medicine, Healthcare, Cannabis, Pharmaceutical

+ My List
CLVRW Clever Leaves Holdings Inc. - Warrant up -7.41% 7.41 + Medicine, Cannabis, Pharmaceutical , Healthcare

+ My List
INM InMed Pharmaceuticals Inc. - Common Shares -4.29% up -8.57% 4.28 + Country: Canada, Pharmaceutical , Medicine, Cannabinoid-based

+ My List
KMPH KemPharm, Inc. - Common Stock -0.31% down 7% -7.31 + Medicine, Pharmaceutical


Last highlighted: #KMPH SEC report: KEMPHARM, INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by KEMPHARM, INC -- SEC File Number 211102850
+ My List
PHVS Pharvaris N.V. - Ordinary Shares 9.54% up 9.34% 0.2 + Medicine, Pharmaceutical


Last highlighted: $PHVS 📜 SEC Form 6-K filed by Pharvaris N.V. https://t.co/Ra28QDTJZ3 15s delayed.
+ My List
TERN Terns Pharmaceuticals, Inc. - Common Stock -0.21% -0.21% 0 + Biopharma, Pharmaceutical , Disease: Liver


Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm) 📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH https://t.co/wJNwFxLOZw #TERN #8K #TernsPharmaceuticals #News
+ My List
VRPX Virpax Pharmaceuticals, Inc. - Common Stock 7.14% up -1.9% 9.04 + Pharmaceutical , Medicine

+ My List
VSPR Vesper Healthcare Acquisition Corp. - Class A Common Stock -5.38% -5.38% 0 + Acquisitions/Investing, Medicine, Pharmaceutical , Healthcare

+ My List
UPC Universe Pharmaceuticals Inc - Ordinary Shares -7.84% -7.84% 0 + Country: China, Pharmaceutical , Medicine

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.